ArticlePloS one2017

Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity.

Michael S D Kormann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.